Plasmodium falciparum

Description
Isolate from a UK-resident adult male of Kenyan origin who had spent three weeks in Nairobi and coastal Kenya. Symptoms arose two weeks after return to the UK, and persisted for one week before attending HTD with 3.6% P. falciparum parasitaemia by microsc
Country
Kenya
Source
Dr. Colin Sutherland
UK Biosafety level
3
Availability
Available. Enquire.
Description
Isolate from a UK-resident adult Nigerian woman who spent two weeks in Lagos with her husband. On return to the UK, symptoms arose, and the patient reported taking two tablets of Nivaquine (probably 200 mg chloroquine-sulphate) four days before presenting
Country
Nigeria
Source
Dr. Colin Sutherland
UK Biosafety level
3
Availability
Available. Enquire.
Description
Obtained from Dr. W Trager, Rockefeller University, New York in October 1978
Country
The Gambia
Source
W. Trager
History
May be FCR3 in disguise
UK Biosafety level
3
Availability
Available. Enquire.

Please state in any acknowledgements:

 

Plasmodium falciparum was obtained from The European Malaria Reagent Repository (http://www.malariaresearch.eu).

It is a condition of the supply of this reagent that you also cite the reference and source given above in any publication.


Contact

Email: emrr@ed.ac.uk